This inventor holds 5 USPTO granted patents. Top assignee: Research, Incorporated. Active years: 1984-1991.
Company Filing History:
Years Active: 1984-1991
Title: The Innovations of Andrew Lasslo
Introduction
Andrew Lasslo is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of medical science, particularly in the area of platelet aggregation. With a total of 5 patents to his name, Lasslo's work has the potential to impact the treatment of various blood-related conditions.
Latest Patents
Among his latest patents, Lasslo has developed innovative platelet aggregation inhibitory agents. One of his notable inventions is related to N,N'-bis(nipecotyl)piperazines, which are used as platelet aggregation inhibitory agents. Another significant patent involves tetrahydroquinoline derivatives, which serve a similar purpose in inhibiting blood platelet aggregation. These inventions highlight his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Lasslo is currently employed at Research, Incorporated, where he continues to explore new avenues in medical research. His work at this institution has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.
Collaborations
Some of his notable coworkers include Ronald P Quintana and Marion Dugdale. Their collaboration has fostered a productive environment for innovation and research.
Conclusion
Andrew Lasslo's contributions to the field of medical science through his patents and collaborations demonstrate his dedication to innovation. His work in developing platelet aggregation inhibitory agents is paving the way for advancements in treatment options for patients.